Houston Methodist is committed to excellence in research, teaching, patient care and the advancement of the art and science of medicine. Houston Methodist is accredited by the Accreditation Council for Continuing Medical Education (ACCME) to provide continuing medical education for physicians.

This website uses cookies to improve website functionality and performance, to analyze website traffic, and to provide you with a more personalized experience. To find out more about the cookies we use, see our Digital Privacy Policy, Disclaimer & Terms of Use.

Neutralizing Monoclonal Antibody Therapy for COVID-19

From Jennifer Swing

views

Dr. Huang discusses the biological rationale and indication for neutralizing monoclonal antibody therapy in ambulatory patients with COVID-19 infections

Tags

Neutralizing Monoclonal Antibody Therapy for COVID-19

Related Media